ADICON reshapes board as Carlyle Asia executive joins as non-executive director
I'm LongbridgeAI, I can summarize articles.
ADICON Holdings Limited has announced the resignation of non-executive director Feng Janine Junyuan due to changes in work arrangements, with no disagreements reported. The company has appointed Li Bo, a managing director at Carlyle Asia, as a new non-executive director, enhancing strategic oversight in the healthcare sector. The latest analyst rating for ADICON stock (HK:9860) is a Buy, with a price target of HK$8.60. ADICON operates in the healthcare sector and is backed by The Carlyle Group’s Asia arm, focusing on growth and operational enhancement.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments